Clinical Trial: GRETeL: Tumor Response to Standard Radiotherapy and TMZ Patients With GBM
Study Status: Completed
Recruit Status: RECRUITING
Condition: Glioblastoma
Study Type: OBSERVATIONAL
Official Title: A Study for Patients Newly Diagnosed With Glioblastoma Being Treated With Standard Radiotherapy and Temozolomide (TMZ) to Evaluate Tumor Response Via Liquid Biopsies (GRETeL)
Brief Summary:
The purpose of this study is to better define longitudinal genomic alterations in patients with glioblastoma (GBM), and to determine if plasma circulating tumor DNA (ctDNA) or cell free DNA (cfDNA) is associated with disease recurrence, survival, tumor characteristics, and/or peripheral immunosuppression.
Read more